Section Arrow
Quote
RADX.NASDAQ
- Radiopharm Theranostics Limited
Quotes are at least 15-min delayed:2025/03/13 18:15 EDT
Last
 5.42
-0.15 (-2.69%)
Day High 
5.6 
Prev. Close
5.57 
1-M High
11 
Volume 
26.49K 
Bid
5.26
Ask
5.65
Day Low
5.1135 
Open
5.57 
1-M Low
4.45 
Market Cap 
43.33M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.97 
20-SMA 5.35 
50-SMA 5.05 
52-W High 50.82 
52-W Low 3.5501 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-18.66/-0.02
Enterprise Value
43.33M
Balance Sheet
Book Value Per Share
4.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
299.23K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc0.0334-0.0234-41.20%0PE
CRVOCervoMed5.79-0.38-6.16%4.66PE
HEPAHepion Pharmaceuticals0.0378-0.011-22.54%-- 
IPAImmunoPrecise Antibodies Ltd0.405+0.0417+11.48%-- 
ONCOOnconetix Inc0.1298-0.0412-24.09%-- 
Quotes are at least 15-min delayed：2025/03/13 18:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.